pyrazines has been researched along with pargyline in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Bianchi, S; Consolo, S; Ghezzi, D; Ladinsky, H; Samanin, R | 1 |
Bowman, Z; Cooper, CM; Stanton, HC | 1 |
Alcaide, B; Almendros, P; Alonso, JM; Fernández, I; Gómez-Campillos, G; Torres, MR | 1 |
Hua, R; Liu, H; Su, J | 1 |
Akagi, Y; Fujioka, S; Inaba, T; Ito, S; Kinoshita, W; Komoda, Y; Kondo, K; Maeda, K; Nakamura, H; Okuda, S; Tamatani, Y; Terui, T; Ukaji, Y | 1 |
5 other study(ies) available for pyrazines and pargyline
Article | Year |
---|---|
Cholinergic-dopaminergic interaction in the striatum: the effect of 6-hydroxydopamine or pimozide treatment on the increased striatal acetylcholine levels induced by apomorphine, piribedil and d-amphetamine.
Topics: Acetylcholine; Amphetamine; Animals; Apomorphine; Choline; Corpus Striatum; Dopamine; Female; Hydroxydopamines; Pargyline; Pimozide; Pyrazines; Rats | 1975 |
Effects of monoamine oxidase inhibitors on isoproterenol-induced cardiomegaly in rats.
Topics: Animals; Carbon Isotopes; Cardiomegaly; DNA; Female; Glycine; Isocarboxazid; Isoniazid; Isoproterenol; Monoamine Oxidase Inhibitors; Myocardium; Nialamide; Nucleic Acids; Pargyline; Phenelzine; Piperidines; Pyrazines; Rats; RNA; Tranylcypromine | 1970 |
A gold-catalysed imine-propargylamine cascade sequence: synthesis of 3-substituted-2,5-dimethylpyrazines and the reaction mechanism.
Topics: Catalysis; Gold; Imines; Models, Molecular; Pargyline; Propylamines; Pyrazines | 2014 |
Au(I)-catalyzed annulation of propargyl amine with aldehydes: one-pot cascade synthesis of 2,5-dimethylpyrazines.
Topics: Aldehydes; Combinatorial Chemistry Techniques; Molecular Structure; Organogold Compounds; Pargyline; Propylamines; Pyrazines | 2015 |
Orally bioavailable HCV NS5A inhibitors of unsymmetrical structural class.
Topics: Administration, Oral; Antiviral Agents; Genotype; Hepacivirus; Hepatitis C; Humans; Mutation; Pargyline; Pyrazines; Structure-Activity Relationship; Viral Nonstructural Proteins; Virus Replication | 2020 |